July 10, 2012 — New and updated evidence-based guidelines to help healthcare providers choose the most appropriate medical imaging exam or radiation therapy for a patient’s clinical condition are now available via the latest version of the American College of Radiology (ACR) Appropriateness Criteria. These continually updated criteria are a national standard, developed by expert panels of physicians from many different medical specialties.

In the latest version, the ACR updated 39 appropriateness criteria topics and added five new criteria — breast cancer screening, radiologic management of gastric varices, imaging of mesenteric ischemia, definitive therapy for early-stage cervical cancer and radiation therapy for small-cell lung cancer. ACR Appropriateness Criteria guide physicians when ordering exams and help ensure that patients get the right scan or therapy for the right indication. The criteria have also been shown to improve quality, reduce unnecessary exams and lower costs.

“In today’s society, evidence-based medicine is critical for the optimal management of cancer patients. Use of ACR Appropriateness Criteria allows physicians to educate themselves regarding the latest evidence-based approach for a wide variety of therapeutic decisions to provide the best care for their patients with cancer,” said Benjamin Movsas, M.D., FACR, chair of the ACR Committee on Radiation Oncology Appropriateness Criteria.

ACR Appropriateness Criteria provide a tool for more effective clinical decision-making and to help ensure that imaging is neither over- nor under-utilized. The criteria include topics from more than 350 expert panelists in breast, cardiac, gastrointestinal, musculoskeletal, neurologic, thoracic, urologic, pediatric, vascular and women’s imaging, as well as interventional radiology and radiation oncology. There are 180 topics with over 850 variants available.

“ACR Appropriateness Criteria can help providers identify when they can replace an exam that uses ionizing radiation with one that does not, or even when no imaging exam may be needed at all. This can reduce patient and population exposure to radiation and ensure appropriate imaging, without disrupting the doctor-patient relationship or delaying needed care,” said E. Kent Yucel, M.D., FACR, chair of the ACR Committee on Diagnostic Imaging and Interventional Radiology Appropriateness Criteria.

For more information: http://www.acr.org/Quality-Safety/Appropriateness-Criteria


Related Content

News | Magnetic Resonance Imaging (MRI)

April 27, 2026 — SimonMed, one of the nation’s largest independent outpatient imaging providers, has announced the ...

Time May 04, 2026
arrow
News | Computed Tomography (CT)

April 23, 2026 — Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Time April 30, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Radiology Business

April 28, 2026 — The American Society of Radiologic Technologists will award Life Member status to three longstanding ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Radiology Business

April 24, 2026 — The 2026 vacancy rate for radiation therapists decreased to 11.4% and the vacancy rate for medical ...

Time April 24, 2026
arrow
News | Artificial Intelligence

April 20, 2026 — DeepTek, provider of the Augmento platform and deepc, the company behind deepcOS, have introduced a ...

Time April 23, 2026
arrow
News | Women's Health

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet ...

Time April 20, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
Subscribe Now